Home
Welcome Note
Committees
International Advisory Board
Confirmed List of Faculty
Guidelines for Speakers
FIGO Post Graduate Course
Preliminary Program
Gynecology
Perinatology
Reproductive Medicine
Timetable
Main Topics
Scientific Program Synopsis
Timetable
Poster Presentations
Group A Posters
Group B Posters
Poster Display Guidelines
Registration & Accommodation
Registration
Accommodation
Swissôtel The Bosphorus
Invitation letter
Congress Information
Before you travel...
General Information
CME
Learners Feedback Questionnaire
Partners
Turkish Agent
Italian Agent
About Istanbul
Sponsorship & Exhibition
Information
Sponsors
Exhibitors
2012 Sponsors
Previous Congresses
BCGIP Barcelona 2012
BCGIP Bangkok 2011
Contact Us
  Gynecology
Print

Times
Thursday, May 30, 2013
HALL C
17:00-19:00
BCGIP (COGI) CONGRESS OPENING SESSION
Chairpersons: Victor Gomel, Canada; Moshe Hod, Israel; Oktay Kadayıfçı, Turkey; Zeev Shoham, Israel
 
Industry support to independent research, legal code and ethical aspects
Amir Lass, Israel
 
New frontiers in Prenatal Diagnosis: From ultrasound to noninvasive prenatal testing
Alfred Abuhamad, USA
 
Istanbul: The old and the new
Victor Gomel, Canada
19:00-20:00
Welcome Reception in the Exhibition Area
Friday, May 31, 2013
HALL A
08:30-10:00
ENDOMETRIOSIS
Capsule: What more should be expected in this mysterious disease?
Chairpersons: Cihat Ünlü, Turkey; Sohani Verma, India; Chen Goldchmit, Israel
 
08:30-08:50
08:50-09:10
Debate: Endometriosis- Surgery vs. Pharmacological Treatment
Surgery: Daniel Seidman, Israel
Pharmacological treatment: Salim Daya, Canada
09:10-09:35
What is the routine investigation in patients with endometriosis?
Jacque Donnez, Belgium
09:35-10:00
 
Adhesion formation: Prevention, is it possible?
Victor Gomel, Canada
10:00-10:30
Coffee Break in the Exhibition Area
10:30-12:30
SAFETY OF ORAL CONTRACEPTION: TIME TO LOOK AGAIN AT THE EVIDENCE
Capsule: First and foremost, a discussion of contraception safety is perhaps the hottest topic today. Should we consider different administration or formulation?
Chairpersons: Amos Ber, Israel; Victor Gomel, Canada
10:30-11:10
Panel Discussion
Gabriele Merki-Feld, Switzerland
Johannes Bitzer, Switzerland
Sven Skouby, Denmark
Bharti Dhorepatil, India  
 
Panel Questions:
Non-stop oral, vaginal and dermal contraception?
What is preferred for emergency contraception: Ulipristal, levonorgestrel, IUD, GnRH antagonist?
Should contraception be given over the counter?
11:10-11:50
New generation oral contraception pills: are they safe?
B.R.K. Sharma, India
11:50-12:30
Debate: Progesterone only contraception: best or worse
For: Gabriele Merki-Feld, Switzerland
Against: Johannes Bitzer, Switzerland
12:30-13:15
Lunch Break in the Exhibition Area
13:15-14:15
Plenary Symposium (Hall B)
FROM SCIENCE FICTION TO REALITY
Capsule: There are tens of thousands of women with absolute uterine factor infertility. Furthermore, societal and regulatory restrictions preclude surrogacy in many parts of the World. Uterus transplant has been vetted in numerous arenas and has emerged as a very reasonable alternative to surrogacy and a supplement to adoption. Although successful pregnancies have been reported in animal models, is the time nearing to consider clinical translation? There are several groups of patients, mostly those treated for cancer and those beyond the reproductive age who will benefit from such technology. Is it real? Nanocarrier-mediated transport and controlled release of substrates at the cancer tissue would be probably to treatment of choice for cancer patients. The current state of this technology.
Chairpersons: Jacque Donnez, Belgium; Antonio Pellicer, Spain (Invitation was initiated by the Turkish Society of Reproductive Medicine)

13:15-13:35

Uterus transplantation
Giuseppe Del Priore, USA

13:35-13:55

The production of sperm and egg from somatic stem cells
Gerald Schatten, USA

13:55-14:15

Regenerative therapy with stem cell either adult and embryonic
Oktay Kadayifci, Turkey
14:15-16:15
MENOPAUSE AND OSTEOPOROSIS: WHAT REALLY BOTHERS MENOPAUSAL WOMEN (COUPLE)?
Organized by & in collaboration with IMS/EMAS & Turkish Menopause and Osteoporosis Society (TMOS)
Capsule: Quality of life should be considered as one of the goals while taking care of the women during menopause. Change in libido and sexual activities interfere life of many couples during this age. Is there any treatment option?
Chairpersons: Shishta N. Basu, India; Hakan Seyisoğlu, Turkey; Sven Skouby, Denmark
14:15-14:45
Sexual aspects
Margaret Rees, UK
14:45-15:15
Individual fracture risk assessment: global variance
Kutay Biberoğlu, Turkey
15:15-15:45
Are calcium and vitamin D supplementation still needed?
Tamer Erel, Turkey
15:45-16:15
Extending the life of older menopausal mice by transplanting ovaries from younger mice:
The role of ovary tissue freezing with later transplantation back to avoid menopause
Sherman Silber, USA
16:15-16:45
Coffee Break in the Exhibition Area
16:45-18:30
MENOPAUSE: SAFETY OF POSTMENOPAUSAL HORMONE THERAPY REVISITED
Organized by & in collaboration with IMS/EMAS & Turkish Menopause and Osteoporosis Society (TMOS)
Capsule: It has been nearly 60 years and the debate on the proper management of the menopausal period is still ongoing. Some of the burning questions may find a solution out of this debate
Chairpersons: Mangala Telang, India; Levent Şentürk, Turkey; Amos Pines, Israel
16:45-17:25
Debate: Should menopause be defined as a pathological state and therefore need to be treated, or is it just a physiological phase to be treated upon complains and symptoms
Pro: Nature knows best: Margaret Rees, UK
Con Science knows best: Zeev Shoham, Israel
  Panel aim: To discuss the clinical and metabolic consequences of menopause and sex hormones deficiency vis-à-vis the benefits and safety of postmenopausal hormone therapy.
17:2-17:45
Aromatase Inhibitors-Induced Osteoporosis in Postmenopausal Women with Breast Cancer
Ümit Inceboz, Turkey
17:45-18:05
The new era of osteoporosis therapies
Fatih Durmuşoğlu, Turkey
18:05-18:25
Cardiovascular perspectives
Amos Pines, Israel
Saturday, June 1, 2013
HALL A
08:30-10:00
CONTRACEPTION: BEAT THE EXPERT
Capsule: Contraception is the common drug taken during the fertility life period. Do we have answers to the most burning questions?
Chairperson: Daniel Seidman, Israel; Gabriele Merki-Feld, Switzerland
08:30-08:55
If the OC can be safe for 3 months, should it be safer for a longer period?
Sven Skouby, Denmark
08:55-09:20
 
Non contraceptive benefits of 17 b- estradiol oral contraceptives
George Creatsas, Greece
09:20-10:00
Panel Discussion:
Johannes Bitzer, Switzerland
Sven Skouby, Denmark
Amos Ber, Israel
  Panel Questions:
Progesterone only contraception- best or worst?
New generation- are they safe?
Emergency contraception- are women really protected?
Pills, IUD, GnRH agonists?
10:00-10:30
Coffee Break in the Exhibition Area
10:30-12:30
ROBOTIC, TELE-SURGERY & LAPAROSCOPY
Capsule: The new technology using robotic surgery is slowly penetrating our practice? Is it justified?
Chairpersons: K.D. Nayar, India; Achim Schneider, Germany; Mordechai Goldenberg, Israel
10:30-11:00
Does Tele-surgery (robotics) add value to endoscopic gynecological procedures?
Michael Stark, Germany
11:00-11:30
Laparoscopic vs. robotic hysterectomy and staging for endometrial cancer
Mete Gungor, Turkey
RECURRENT ABORTIONS
Capsule: Recurrent loss of pregnancies is a frustrating condition. The routine workup includes hormonal examination, genetic screening, immunologic and thrombophilic testing, and uterine defects. Is there any shortcut in the evaluation process and treatment?
Chairpersons: Salim Daya, Canada; George Creatsas, Greece
11:30-12:00
Treatment of immunology caused implantation failure
Milton Leong, Hong Kong
12:00-12:30
Is progesterone the answer? If so what should be the formulation? Oral, Vaginal, IM?
Sonia Malik, India
12:30-14:15
Lunch Break in the Exhibition Area
13:15-14:15
Plenary Symposium (Hall B)
Critical evaluation of Prediction and Prevention of Preeclampsia
Chairpersons: Riza Madazli, Turkey; Francesc Figueras, Spain

Is there a role of uterine Doppler screening
Elisa Llurba, Spain

Risk stratification of hypertensive pregnancy disorders
Stefan Verlohren, Germany

Critical evaluation: Is prediction of preeclampsia possible?
Francesc Figueras, Spain

Critical evaluation: The use of low molecular weight heparin as prophylactic therapy in women at high risk for PET
Jacob Bar, Israel
14:15-16:15
ENDOSCOPY
Capsule: With the fast development of technology, the procedure is becoming easier and more simple
Chairpersons: Gouri Devi, India; Mete Gungor, Turkey; Victor Gomel, Canada
14:15-15:00
Debate: Laparoscopy in infertility investigation
Pro: Jacques Donnez, Belgium
Con: Hikmet Hassa, Turkey
15:00-15:45
Debate: Single port laparoscopy?
A real advantage or just a new gimmick?
Polat Dursun, Turkey
Traditional laparoscopy is still the simple one
Chen Goldchmit, Israel
15:45-16:15
Is there a limit to the size of the uterus you can take out in laparoscopy?
Mordechai Goldenberg, Israel
16:15-16:30
Coffee Break in the Exhibition Area
16:30-18:30
FIBROIDS: DOES THIS CHAPTER NEED TO BE REWRITTEN? AN OPEN DEBATE
Capsule: The multidisciplinary approach for the treatment of uterine fibroids
Chairperson: Sudha Prasad, India; George Creatsas, Greece; Mordechai Goldenberg, Israel
16:30-17:00
The use of progesterone medicated IUD
Amos Ber, Israel
17:00-17:30
The use of Ulipersitol
Jacques Donnez, Belgium
17:30-18:00
The use of GnRH agonist
Daniel Seidman, Israel
18:00-18:30
Hysterectomy vs. Myomectomy in the older patient?
Chen Goldchmit, Israel

Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 10/03/2013 Created by     WebStudio.co.il